BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 26524643)

  • 21. Prevalence of pancreatic cystic lesions including intraductal papillary mucinous neoplasms in patients with end-stage renal disease on hemodialysis.
    Ishikawa T; Takeda K; Itoh M; Imaizumi T; Oguri K; Takahashi H; Kasuga H; Toriyama T; Matsuo S; Hirooka Y; Itoh A; Kawashima H; Kasugai T; Ohno E; Miyahara R; Ishigami M; Katano Y; Ohmiya N; Niwa Y; Goto H
    Pancreas; 2009 Mar; 38(2):175-9. PubMed ID: 18824946
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Incidence and characteristics of pancreatic cystic neoplasms].
    Adet A; Miquel R; Bombi JA; Gines A; Fernández-Esparrach G; De Juan C; Ayuso JR; Maurel J; Castells A; Fernández-Cruz L; Navarro S
    Gastroenterol Hepatol; 2010 Oct; 33(8):563-8. PubMed ID: 20850905
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vascular endothelial growth factor, a novel and highly accurate pancreatic fluid biomarker for serous pancreatic cysts.
    Yip-Schneider MT; Wu H; Dumas RP; Hancock BA; Agaram N; Radovich M; Schmidt CM
    J Am Coll Surg; 2014 Apr; 218(4):608-17. PubMed ID: 24491241
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Should we do EUS/FNA on patients with pancreatic cysts? The incremental diagnostic yield of EUS over CT/MRI for prediction of cystic neoplasms.
    Khashab MA; Kim K; Lennon AM; Shin EJ; Tignor AS; Amateau SK; Singh VK; Wolfgang CL; Hruban RH; Canto MI
    Pancreas; 2013 May; 42(4):717-21. PubMed ID: 23558241
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Risk of Neoplastic Progression in Individuals at High Risk for Pancreatic Cancer Undergoing Long-term Surveillance.
    Canto MI; Almario JA; Schulick RD; Yeo CJ; Klein A; Blackford A; Shin EJ; Sanyal A; Yenokyan G; Lennon AM; Kamel IR; Fishman EK; Wolfgang C; Weiss M; Hruban RH; Goggins M
    Gastroenterology; 2018 Sep; 155(3):740-751.e2. PubMed ID: 29803839
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Noninvasive intraductal papillary mucinous neoplasms and mucinous cystic neoplasms: recurrence rates and postoperative imaging follow-up.
    Xourafas D; Tavakkoli A; Clancy TE; Ashley SW
    Surgery; 2015 Mar; 157(3):473-83. PubMed ID: 25596773
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intraductal papillary mucinous neoplasms of the pancreas with concurrent pancreatic and periampullary neoplasms.
    Sahora K; Crippa S; Zamboni G; Ferrone C; Warshaw AL; Lillemoe K; Mino-Kenudson M; Falconi M; Fernandez-del Castillo C
    Eur J Surg Oncol; 2016 Feb; 42(2):197-204. PubMed ID: 26687069
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CT attenuation of unilocular pancreatic cystic lesions to differentiate pseudocysts from mucin-containing cysts.
    Chalian H; Töre HG; Miller FH; Yaghmai V
    JOP; 2011 Jul; 12(4):384-8. PubMed ID: 21737901
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical Outcomes of Endoscopic Ultrasonography-Guided Pancreatic Cyst Ablation.
    Park JK; Song BJ; Ryu JK; Paik WH; Park JM; Kim J; Lee SH; Kim YT
    Pancreas; 2016 Jul; 45(6):889-94. PubMed ID: 26765962
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Incidence and Prevalence of Intraductal Papillary Mucinous Neoplasms in Individuals With BRCA1 and BRCA2 Pathogenic Variant.
    Shah I; Silva-Santisteban A; Germansky KA; Wadhwa V; Tung N; Huang DC; Kandasamy C; Mlabasati J; Bilal M; Sawhney MS
    J Clin Gastroenterol; 2023 Mar; 57(3):317-323. PubMed ID: 35220378
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Incidence of synchronous and metachronous pancreatic carcinoma in 168 patients with branch duct intraductal papillary mucinous neoplasm.
    Tanno S; Nakano Y; Sugiyama Y; Nakamura K; Sasajima J; Koizumi K; Yamazaki M; Nishikawa T; Mizukami Y; Yanagawa N; Fujii T; Obara T; Okumura T; Kohgo Y
    Pancreatology; 2010; 10(2-3):173-8. PubMed ID: 20484955
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The outcome of resected cystic pancreatic endocrine neoplasms: a case-matched analysis.
    Gaujoux S; Tang L; Klimstra D; Gonen M; Brennan MF; D'Angelica M; DeMatteo R; Fong Y; Jarnagin W; Allen PJ
    Surgery; 2012 Apr; 151(4):518-25. PubMed ID: 22088817
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Natural history of pancreatic cystic lesions: A multicenter prospective observational study for evaluating the risk of pancreatic cancer.
    Ohno E; Hirooka Y; Kawashima H; Ishikawa T; Kanamori A; Ishikawa H; Sasaki Y; Nonogaki K; Hara K; Hashimoto S; Matsubara H; Hirai T; Sumi H; Sugimoto H; Goto H;
    J Gastroenterol Hepatol; 2018 Jan; 33(1):320-328. PubMed ID: 28872701
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Longterm follow-up of small pancreatic cystic lesions in liver transplant recipients.
    Vidhyarkorn S; Siripongsakun S; Yu J; Sayre J; Agopian VG; Durazo F; Lu DS
    Liver Transpl; 2017 Mar; 23(3):324-329. PubMed ID: 27875639
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Resection of pancreatic cystic neoplasms in recurrent acute pancreatitis prevents recurrent pancreatitis but does not identify more malignancies.
    Muniraj T; Aslanian HR; Laine L; Jamidar PA; Farrell JF; Mitchell KA; Salem RR
    World J Gastroenterol; 2021 Apr; 27(15):1630-1642. PubMed ID: 33958848
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevalence, Diagnosis and Management of Pancreatic Cystic Neoplasms: Current Status and Future Directions.
    Farrell JJ
    Gut Liver; 2015 Sep; 9(5):571-89. PubMed ID: 26343068
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Risk Factors for Pancreatic Cancer and the Necessity of Long-Term Surveillance in Patients With Pancreatic Cystic Lesions.
    Yoshioka T; Shigekawa M; Ikezawa K; Tamura T; Sato K; Urabe M; Sueyoshi H; Yamai T; Suda T; Sakamori R; Tatsumi T; Takehara T
    Pancreas; 2020 Apr; 49(4):552-560. PubMed ID: 32282769
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of endoscopic ultrasound in the management of intraductal papillary mucinous neoplasms: a systematic update.
    Smith LA; McKay CJ
    Minerva Med; 2016 Dec; 107(6):370-380. PubMed ID: 27627636
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intraductal papillary mucinous neoplasms of the pancreas: clinical surveillance and malignant progression, multifocality and implications of a field-defect.
    Remotti HE; Winner M; Saif MW
    JOP; 2012 Mar; 13(2):135-8. PubMed ID: 22406584
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Value of EUS in early detection of pancreatic ductal adenocarcinomas in patients with intraductal papillary mucinous neoplasms.
    Kamata K; Kitano M; Kudo M; Sakamoto H; Kadosaka K; Miyata T; Imai H; Maekawa K; Chikugo T; Kumano M; Hyodo T; Murakami T; Chiba Y; Takeyama Y
    Endoscopy; 2014 Jan; 46(1):22-9. PubMed ID: 24218310
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.